Income Taxes (Details) - Schedule of Income Tax (Benefit) Expense Amount Computed At the Federal Statutory Corporate - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Schedule of Income Tax (Benefit) Expense Amount Computed At the Federal Statutory Corporate [Abstract] | |||
| Tax (provision) benefit at Federal statutory rate | $ (25,454) | $ 25,293 | $ 299 |
| State income tax provision (benefit), net of federal benefit | (6,235) | 292 | (821) |
| Noncontrolling interest | 96 | 59 | (418) |
| Tax receivable agreement liability | (34,014) | (843) | |
| Change in fair value – warrant liabilities | (912) | (5,051) | |
| Change in valuation allowance | 35,592 | 189,870 | |
| Remeasurement due to rate change | (31) | 2,530 | 3,287 |
| Research and development tax credits | (1,113) | (1,763) | |
| Remeasurement of investment in Purple LLC | (4,028) | 29,822 | 1,834 |
| Nondeductible compensation | 281 | 531 | |
| Stock-based compensation | 605 | 2,303 | (330) |
| Other | 295 | (311) | (10) |
| Income tax (benefit) expense | $ 8 | $ 213,169 | $ (1,522) |
| X | ||||||||||
- Definition Remeasurement of investment. No definition available.
|
| X | ||||||||||
- Definition Tax receivable agreement liability. No definition available.
|
| X | ||||||||||
- Definition Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Change during the period in carrying value for all deferred liabilities due within one year or operating cycle. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) attributable to other nonredeemable noncontrolling equity holder. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|